Skip to main content
. 2023 Sep 5;108(6):852–858. doi: 10.1136/bjo-2023-323577

Figure 1.

Figure 1

(A) Maximum SHRM thickness and (B) percentage reduction in maximum SHRM thickness in the macula up to week 96 among patients in the brolucizumab and aflibercept arms of the pooled HAWK and HARRIER studies. SHRM, subretinal hyper-reflective material.